Monthly Subscription
Unlimited document downloads
$99


Custom Document Search
Locate hard-to-find documents, quickly and inexpensively
$59

See also:

Watch List
company_intel Hi-Tech Pharmacal Co.


The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$39
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Additional Investment Right Hi-Tech Pharmacal Co.
$65
 Subscribers Subscribers
Preview 		2005
 ContractIntelligence Agreement of Merger and Plan of Reorganization Accentia Biopharmaceuticals;
Accentia 		Hi-Tech
$53
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Asset Purchase Agreement Amarin;
Amerisource;
Cardinal Health 		Elan Pharma
Entity 2 3
$51
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Asset Purchase Agreement
[Amended and Restated] 		Amarin;
Elan Pharma 		Hi-Tech
$34
 Subscribers Subscribers
Preview 		2002
 ContractIntelligence Employment Agreement Arthur S. Goldberg Hi-Tech Pharmacal Co.
$35
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Employment Agreement
[Amended and Restated] 		Bernard Seltzer Hi-Tech Pharmacal Co.
$35
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Employment Agreement
[Amended and Restated] 		Arthur S. Goldberg Hi-Tech Pharmacal Co.
$34
 Subscribers Subscribers
2004
 ContractIntelligence Executive Employment Agreement Hi-Tech Pharmacal Co.
$36
 Subscribers Subscribers
Preview 		2000
 ContractIntelligence Executive Employment Agreement
[Amended and Restated] 		David S. Seltzer Hi-Tech Pharmacal Co.
$31
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Executive Employment Agreement
[Amended and Restated]
[Amendment No. 1] 		David Seltzer Hi-Tech Pharmacal Co.
$33
 Subscribers Subscribers
2004
 ContractIntelligence HI-Tech Pharmacal Acquires Exclusive Rights to Naprelan(R) Hi-Tech Pharmacal Co.
$38
 Subscribers Subscribers
2004
 ContractIntelligence HI-Tech Pharmacal Announces Retirement Of Chief Financial Officer and Appontment of New CFO Hi-Tech Pharmacal Co. Merck & Co., Inc.
$33
 Subscribers Subscribers
2003
 ContractIntelligence HI-Tech Pharmacal Co., Inc. Announces $25 Million Private Placement of Common Stock Hi-Tech Pharmacal Co.
$37
 Subscribers Subscribers
2003
 ContractIntelligence HI-Tech Pharmacal Provides Fiscal 2004 Revenue Guidance Hi-Tech Pharmacal Co.
$35
 Subscribers Subscribers
2003
 ContractIntelligence HI-Tech Pharmacal Reports 33% Increase in Sales and 50% Increase in Net Income for Its Fiscal Second Quarter Hi-Tech Pharmacal Co.
$33
 Subscribers Subscribers
2003
 ContractIntelligence HI-Tech Pharmacal Reports 63% Increase in Net Income For the Fiscal Year Ended April 30, 2003 Hi-Tech Pharmacal Co.
$36
 Subscribers Subscribers
2004
 ContractIntelligence HI-Tech Pharmacal Reports a 13% Sales Increase and a 12% Net Income Increase for the Quarter and an 18% Sales Increase and a 24% Net Income Increase for the 9 Months Ending January 31 Hi-Tech Pharmacal Co.
$30
 Subscribers Subscribers
2004
 ContractIntelligence HI-Tech Pharmacal Reports a 23% Sales Increase for the Quarter Ended April 30, 2004 Hi-Tech Pharmacal Co.
$37
 Subscribers Subscribers
2003
 ContractIntelligence HI-Tech Pharmacal Reports Increase in Quarterly Sales And Net Income Hi-Tech Pharmacal Co.
$41
 Subscribers Subscribers
Preview 		2005
 ContractIntelligence License and Supply Agreement BioMarin Pharmaceutical Inc. Hi-Tech Pharmacal Co.